TY - JOUR
T1 - Staging and prognostic factors in nonseminomatous testicular cancer
AU - Murphy, P.
AU - Johnson, D. H.
PY - 1991
Y1 - 1991
N2 - Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.
AB - Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.
UR - http://www.scopus.com/inward/record.url?scp=0025841895&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025841895&partnerID=8YFLogxK
U2 - 10.1016/s0889-8588(18)30381-2
DO - 10.1016/s0889-8588(18)30381-2
M3 - Article
C2 - 1663942
AN - SCOPUS:0025841895
SN - 0889-8588
VL - 5
SP - 1233
EP - 1243
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 6
ER -